IBIO stock forecast
Our latest prediction for iBio, Inc.'s stock price was made on the Nov. 30, 2017 when the stock price was at 1.90$.
In the short term (2weeks), IBIO's stock price should outperform the market by 5.77%. During that period the price should oscillate between -10.01% and +23.26%.
In the medium term (3months), IBIO's stock price should outperform the market by 12.11%. During that period the price should oscillate between -19.75% and +56.69%.Get email alerts
About iBio, Inc.
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.37$ per share.
The book value per share is 0.88$
Three months stock forecastNov. 30, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|